Abstract
Systemic lupus erythematosus is a multisystem inflammatory disease characterized by antinuclear antibody production. The diagnosis of this disease is established on the basis of a constellation of clinical and serologic features. Therapy is directed to specific disease manifestations and involves an array of anti-inflammatory and immunosuppressive agents that are administered judiciously to limit toxicity.
MeSH terms
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Antinuclear / biosynthesis
-
Antibodies, Antinuclear / blood
-
Arthritis / drug therapy
-
Disease Progression
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Lupus Erythematosus, Systemic / blood
-
Lupus Erythematosus, Systemic / diagnosis*
-
Lupus Erythematosus, Systemic / drug therapy
-
Lupus Erythematosus, Systemic / immunology
-
Lupus Nephritis / drug therapy
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Antinuclear
-
Immunosuppressive Agents